Thymopentin
Records for this ingredient, by country (identity only).
ATC L03AX · 1 markets · 114 records
CN 114 records · 4 shown of 4
- 1 mg per mL / per unit basis not statedinjection和信胸腺五肽替波定、Manufacturer: 上海华源药业(宁夏)沙赛制药有限公司、Manufacturer: 北京双鹭药业股份有限公司、Manufacturer: 华润双鹤药业股份有限公司、Manufacturer: 南京海辰药业股份有限公司、Manufacturer: 南京绿叶制药有限公司、Manufacturer: 双鹤药业(海南)有限责任公司、Manufacturer: 吉林敖东药业集团延吉股份有限公司 +30
- 10 mg per mL / per unit basis not statedinjection和信胸腺五肽替波定、Manufacturer: 上海华源药业(宁夏)沙赛制药有限公司、Manufacturer: 北京双鹭药业股份有限公司、Manufacturer: 国药一心制药有限公司、Manufacturer: 武汉华龙生物制药有限公司、Manufacturer: 深圳翰宇药业股份有限公司
- 1 mg/1 mLinjection和信胸腺五肽Manufacturer: 北京世桥生物制药有限公司、Manufacturer: 北京双鹭药业股份有限公司
- 10 mg/1 mLinjection和信胸腺五肽Manufacturer: 北京世桥生物制药有限公司
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.